25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Farmacosmo SpA
Buy, Hold or Sell?

Let's analyze Farmacosmo together

I guess you are interested in Farmacosmo SpA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Farmacosmo SpA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Farmacosmo SpA

I send you an email if I find something interesting about Farmacosmo SpA.

1. Quick Overview

1.1. Quick analysis of Farmacosmo (30 sec.)










1.2. What can you expect buying and holding a share of Farmacosmo? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
€0.40
Expected worth in 1 year
€0.14
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
€-0.26
Return On Investment
-68.3%

For what price can you sell your share?

Current Price per Share
€0.38
Expected price per share
€0 - €0.648
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Farmacosmo (5 min.)




Live pricePrice per Share (EOD)
€0.38

2.2. Growth of Farmacosmo (5 min.)




Is Farmacosmo growing?

Current yearPrevious yearGrowGrow %
How rich?$16.1m$18.2m-$2.1m-13.2%

How much money is Farmacosmo making?

Current yearPrevious yearGrowGrow %
Making money-$3.3m-$2.1m-$1.2m-38.0%
Net Profit Margin-4.5%-3.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Farmacosmo (5 min.)




2.4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Farmacosmo?

Welcome investor! Farmacosmo's management wants to use your money to grow the business. In return you get a share of Farmacosmo.

First you should know what it really means to hold a share of Farmacosmo. And how you can make/lose money.

Speculation

The Price per Share of Farmacosmo is €0.381. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Farmacosmo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Farmacosmo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.40. Based on the TTM, the Book Value Change Per Share is €-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is €0.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Farmacosmo.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.09-22.9%-0.09-22.9%-0.06-14.6%-0.02-6.0%-0.02-6.0%
Usd Book Value Change Per Share-0.07-17.9%-0.07-17.9%0.45119.2%0.0821.8%0.0821.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.3%0.000.3%
Usd Total Gains Per Share-0.07-17.9%-0.07-17.9%0.45119.2%0.0822.1%0.0822.1%
Usd Price Per Share0.72-0.72-2.04-0.55-0.55-
Price to Earnings Ratio-8.24--8.24--36.70--8.99--8.99-
Price-to-Total Gains Ratio-10.55--10.55-4.50--3.02--3.02-
Price to Book Ratio1.73-1.73-4.23-1.19-1.19-
Price-to-Total Gains Ratio-10.55--10.55-4.50--3.02--3.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3992499
Number of shares2504
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.08
Usd Total Gains Per Share-0.070.08
Gains per Quarter (2504 shares)-170.61210.89
Gains per Year (2504 shares)-682.45843.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-682-69212831834
20-1365-13742416631678
30-2047-20563624942522
40-2730-27384833263366
50-3412-34206041574210
60-4095-41027349895054
70-4777-47848558205898
80-5460-54669766526742
90-6142-614810974837586
100-6825-683012183158430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%4.01.00.080.0%4.01.00.080.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.04.020.0%1.00.04.020.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%4.01.00.080.0%4.01.00.080.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Farmacosmo SpA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.065-0.0650%0.433-115%0.079-182%0.079-182%
Book Value Per Share--0.3960.3960%0.461-14%0.182+117%0.182+117%
Current Ratio--0.9880.9880%1.154-14%1.015-3%1.015-3%
Debt To Asset Ratio--0.5780.5780%0.557+4%0.780-26%0.780-26%
Debt To Equity Ratio--1.6281.6280%1.255+30%7.863-79%7.863-79%
Dividend Per Share----0%-0%0.001-100%0.001-100%
Eps---0.083-0.0830%-0.053-36%-0.022-74%-0.022-74%
Free Cash Flow Per Share---0.183-0.1830%---0.052-72%-0.052-72%
Free Cash Flow To Equity Per Share---0.183-0.1830%---0.049-73%-0.049-73%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap13226834.100-101%26624429.00626624429.0060%73572271.500-64%20039340.101+33%20039340.101+33%
Net Profit Margin---0.045-0.0450%-0.031-32%-0.011-76%-0.011-76%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.9811.9810%1.993-1%1.754+13%1.754+13%
Pb Ratio0.962-80%1.7321.7320%4.229-59%1.192+45%1.192+45%
Pe Ratio-4.576+44%-8.239-8.2390%-36.699+345%-8.988+9%-8.988+9%
Price Per Share0.381-80%0.6860.6860%1.950-65%0.527+30%0.527+30%
Price To Free Cash Flow Ratio-2.085+44%-3.754-3.7540%--100%-0.751-80%-0.751-80%
Price To Total Gains Ratio-5.860+44%-10.550-10.5500%4.501-334%-3.025-71%-3.025-71%
Quick Ratio--0.2440.2440%0.900-73%0.679-64%0.679-64%
Return On Assets---0.089-0.0890%-0.051-42%-0.006-93%-0.006-93%
Return On Equity---0.250-0.2500%-0.115-54%0.217-215%0.217-215%
Total Gains Per Share---0.065-0.0650%0.433-115%0.080-181%0.080-181%
Usd Book Value--16109375.08316109375.0830%18231112.704-12%7266536.383+122%7266536.383+122%
Usd Book Value Change Per Share---0.068-0.0680%0.454-115%0.083-182%0.083-182%
Usd Book Value Per Share--0.4150.4150%0.483-14%0.191+117%0.191+117%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps---0.087-0.0870%-0.056-36%-0.023-74%-0.023-74%
Usd Free Cash Flow---7431183.898-7431183.8980%--100%-1663000.743-78%-1663000.743-78%
Usd Free Cash Flow Per Share---0.191-0.1910%---0.054-72%-0.054-72%
Usd Free Cash Flow To Equity Per Share---0.191-0.1910%---0.051-73%-0.051-73%
Usd Market Cap13860399.453-101%27899739.15527899739.1550%77096383.305-64%20999224.492+33%20999224.492+33%
Usd Price Per Share0.399-80%0.7190.7190%2.043-65%0.552+30%0.552+30%
Usd Profit---3386360.107-3386360.1070%-2100777.525-38%-904651.651-73%-904651.651-73%
Usd Revenue--74999740.26974999740.2690%68803437.360+9%55246050.242+36%55246050.242+36%
Usd Total Gains Per Share---0.068-0.0680%0.454-115%0.084-181%0.084-181%
 EOD+3 -5MRQTTM+0 -0YOY+5 -235Y+10 -2410Y+10 -24

3.3 Fundamental Score

Let's check the fundamental score of Farmacosmo SpA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.576
Price to Book Ratio (EOD)Between0-10.962
Net Profit Margin (MRQ)Greater than0-0.045
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.244
Current Ratio (MRQ)Greater than10.988
Debt to Asset Ratio (MRQ)Less than10.578
Debt to Equity Ratio (MRQ)Less than11.628
Return on Equity (MRQ)Greater than0.15-0.250
Return on Assets (MRQ)Greater than0.05-0.089
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Farmacosmo SpA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.491
Ma 20Greater thanMa 500.555
Ma 50Greater thanMa 1000.625
Ma 100Greater thanMa 2000.671
OpenGreater thanClose0.400
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Farmacosmo SpA

Farmacosmo S.p.A. operates as an online pharmacy and beauty store company in Italy. It offers health and pharmacy, bath and body, skincare, haircare, sun and tanning, dental care, fragrance, make up, baby and child, and organic and natural products, as well as vitamins and supplements, toys, food cupboards, pets, and household products. The company is headquartered in Naples, Italy.

Fundamental data was last updated by Penke on 2024-11-23 01:39:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Farmacosmo earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Farmacosmo to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of -4.5% means that €-0.05 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Farmacosmo SpA:

  • The MRQ is -4.5%. The company is making a loss. -1
  • The TTM is -4.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-4.5%TTM-4.5%0.0%
TTM-4.5%YOY-3.1%-1.5%
TTM-4.5%5Y-1.1%-3.4%
5Y-1.1%10Y-1.1%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.5%1.0%-5.5%
TTM-4.5%0.7%-5.2%
YOY-3.1%0.9%-4.0%
5Y-1.1%1.7%-2.8%
10Y-1.1%1.5%-2.6%
4.3.1.2. Return on Assets

Shows how efficient Farmacosmo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Farmacosmo to the Pharmaceutical Retailers industry mean.
  • -8.9% Return on Assets means that Farmacosmo generated €-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Farmacosmo SpA:

  • The MRQ is -8.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.9%TTM-8.9%0.0%
TTM-8.9%YOY-5.1%-3.8%
TTM-8.9%5Y-0.6%-8.3%
5Y-0.6%10Y-0.6%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.9%0.4%-9.3%
TTM-8.9%0.4%-9.3%
YOY-5.1%0.3%-5.4%
5Y-0.6%0.5%-1.1%
10Y-0.6%0.3%-0.9%
4.3.1.3. Return on Equity

Shows how efficient Farmacosmo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Farmacosmo to the Pharmaceutical Retailers industry mean.
  • -25.0% Return on Equity means Farmacosmo generated €-0.25 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Farmacosmo SpA:

  • The MRQ is -25.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.0%TTM-25.0%0.0%
TTM-25.0%YOY-11.5%-13.5%
TTM-25.0%5Y21.7%-46.8%
5Y21.7%10Y21.7%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.0%1.4%-26.4%
TTM-25.0%1.2%-26.2%
YOY-11.5%1.7%-13.2%
5Y21.7%1.8%+19.9%
10Y21.7%0.8%+20.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Farmacosmo SpA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Farmacosmo is operating .

  • Measures how much profit Farmacosmo makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Farmacosmo to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Farmacosmo SpA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.0%-1.0%
TTM-0.8%-0.8%
YOY-1.5%-1.5%
5Y-1.7%-1.7%
10Y-1.7%-1.7%
4.3.2.2. Operating Ratio

Measures how efficient Farmacosmo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 1.98 means that the operating costs are €1.98 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Farmacosmo SpA:

  • The MRQ is 1.981. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.981. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.981TTM1.9810.000
TTM1.981YOY1.993-0.012
TTM1.9815Y1.754+0.227
5Y1.75410Y1.7540.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9811.480+0.501
TTM1.9811.218+0.763
YOY1.9931.146+0.847
5Y1.7541.174+0.580
10Y1.7541.170+0.584
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Farmacosmo SpA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Farmacosmo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 0.99 means the company has €0.99 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Farmacosmo SpA:

  • The MRQ is 0.988. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.988. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.988TTM0.9880.000
TTM0.988YOY1.154-0.165
TTM0.9885Y1.015-0.027
5Y1.01510Y1.0150.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9881.263-0.275
TTM0.9881.270-0.282
YOY1.1541.181-0.027
5Y1.0151.315-0.300
10Y1.0151.451-0.436
4.4.3.2. Quick Ratio

Measures if Farmacosmo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Farmacosmo to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.24 means the company can pay off €0.24 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Farmacosmo SpA:

  • The MRQ is 0.244. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.244. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.244TTM0.2440.000
TTM0.244YOY0.900-0.656
TTM0.2445Y0.679-0.436
5Y0.67910Y0.6790.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2440.499-0.255
TTM0.2440.546-0.302
YOY0.9000.596+0.304
5Y0.6790.657+0.022
10Y0.6790.881-0.202
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Farmacosmo SpA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Farmacosmo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Farmacosmo to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.58 means that Farmacosmo assets are financed with 57.8% credit (debt) and the remaining percentage (100% - 57.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Farmacosmo SpA:

  • The MRQ is 0.578. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.578. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.578TTM0.5780.000
TTM0.578YOY0.557+0.021
TTM0.5785Y0.780-0.203
5Y0.78010Y0.7800.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5780.638-0.060
TTM0.5780.651-0.073
YOY0.5570.690-0.133
5Y0.7800.640+0.140
10Y0.7800.601+0.179
4.5.4.2. Debt to Equity Ratio

Measures if Farmacosmo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Farmacosmo to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 162.8% means that company has €1.63 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Farmacosmo SpA:

  • The MRQ is 1.628. The company is just able to pay all its debts with equity.
  • The TTM is 1.628. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.628TTM1.6280.000
TTM1.628YOY1.255+0.373
TTM1.6285Y7.863-6.235
5Y7.86310Y7.8630.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6281.607+0.021
TTM1.6281.745-0.117
YOY1.2552.191-0.936
5Y7.8631.982+5.881
10Y7.8631.661+6.202
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Farmacosmo generates.

  • Above 15 is considered overpriced but always compare Farmacosmo to the Pharmaceutical Retailers industry mean.
  • A PE ratio of -8.24 means the investor is paying €-8.24 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Farmacosmo SpA:

  • The EOD is -4.576. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.239. Based on the earnings, the company is expensive. -2
  • The TTM is -8.239. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.576MRQ-8.239+3.663
MRQ-8.239TTM-8.2390.000
TTM-8.239YOY-36.699+28.460
TTM-8.2395Y-8.988+0.749
5Y-8.98810Y-8.9880.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-4.57614.140-18.716
MRQ-8.23914.811-23.050
TTM-8.2399.576-17.815
YOY-36.69911.917-48.616
5Y-8.9886.631-15.619
10Y-8.98814.310-23.298
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Farmacosmo SpA:

  • The EOD is -2.085. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.754. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.754. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.085MRQ-3.754+1.669
MRQ-3.754TTM-3.7540.000
TTM-3.754YOY--3.754
TTM-3.7545Y-0.751-3.004
5Y-0.75110Y-0.7510.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-2.0852.455-4.540
MRQ-3.7542.407-6.161
TTM-3.7542.444-6.198
YOY-0.223-0.223
5Y-0.7512.853-3.604
10Y-0.751-0.253-0.498
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Farmacosmo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 1.73 means the investor is paying €1.73 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Farmacosmo SpA:

  • The EOD is 0.962. Based on the equity, the company is cheap. +2
  • The MRQ is 1.732. Based on the equity, the company is underpriced. +1
  • The TTM is 1.732. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.962MRQ1.732-0.770
MRQ1.732TTM1.7320.000
TTM1.732YOY4.229-2.497
TTM1.7325Y1.192+0.540
5Y1.19210Y1.1920.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD0.9621.077-0.115
MRQ1.7321.284+0.448
TTM1.7321.466+0.266
YOY4.2291.299+2.930
5Y1.1921.837-0.645
10Y1.1922.937-1.745
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Retained Earnings  312173485413898-523376-6,180-5,804



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets36,400
Total Liabilities21,027
Total Stockholder Equity12,915
 As reported
Total Liabilities 21,027
Total Stockholder Equity+ 12,915
Total Assets = 36,400

Assets

Total Assets36,400
Total Current Assets20,110
Long-term Assets16,290
Total Current Assets
Cash And Cash Equivalents 5,065
Net Receivables 4,955
Inventory 7,332
Total Current Assets  (as reported)20,110
Total Current Assets  (calculated)17,352
+/- 2,757
Long-term Assets
Property Plant Equipment 494
Goodwill 10,851
Intangible Assets 4,822
Long-term Assets  (as reported)16,290
Long-term Assets  (calculated)16,167
+/- 123

Liabilities & Shareholders' Equity

Total Current Liabilities20,347
Long-term Liabilities680
Total Stockholder Equity12,915
Total Current Liabilities
Accounts payable 19,916
Total Current Liabilities  (as reported)20,347
Total Current Liabilities  (calculated)19,916
+/- 431
Long-term Liabilities
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)680
Long-term Liabilities  (calculated)0
+/- 680
Total Stockholder Equity
Total Stockholder Equity (as reported)12,915
Total Stockholder Equity (calculated)0
+/- 12,915
Other
Capital Stock3,481
Common Stock Shares Outstanding 38,811
Net Invested Capital 12,915
Net Working Capital -237
Property Plant and Equipment Gross 1,042



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
4,785
8,707
10,769
39,239
36,400
36,40039,23910,7698,7074,785
   > Total Current Assets 
3,982
7,663
9,263
21,843
20,110
20,11021,8439,2637,6633,982
       Cash And Cash Equivalents 
810
1,968
1,391
6,778
5,065
5,0656,7781,3911,968810
       Net Receivables 
2,315
4,259
4,810
10,185
4,955
4,95510,1854,8104,2592,315
       Inventory 
529
978
2,080
4,731
7,332
7,3324,7312,080978529
   > Long-term Assets 
784
1,026
0
17,395
16,290
16,29017,39501,026784
       Property Plant Equipment 
194
192
296
483
494
494483296192194
       Goodwill 
3
3
2
11,181
10,851
10,85111,181233
       Intangible Assets 
578
813
1,099
5,106
4,822
4,8225,1061,099813578
> Total Liabilities 
4,404
8,153
9,802
21,841
21,027
21,02721,8419,8028,1534,404
   > Total Current Liabilities 
4,254
7,947
8,976
18,933
20,347
20,34718,9338,9767,9474,254
       Short-term Debt 
5
103
240
0
0
002401035
       Short Long Term Debt 
0
0
0
1,870
0
01,870000
       Accounts payable 
3,983
7,243
0
19,117
19,916
19,91619,11707,2433,983
       Other Current Liabilities 
4
2
0
587
0
0587024
   > Long-term Liabilities 
102
254
0
562
680
6805620254102
       Long term Debt Total 
0
0
381
692
0
069238100
       Long term Debt 
5
103
381
692
0
06923811035
       Long-term Liabilities Other 
-1
0
0
0
0
0000-1
> Total Stockholder Equity
381
554
967
17,398
12,915
12,91517,398967554381
   Common Stock
68
68
68
3,009
0
03,009686868
   Retained Earnings 
312
485
898
376
-5,804
-5,804376898485312
   Capital Surplus 
0
0
0
14,263
0
014,263000
   Treasury Stock00000
   Other Stockholders Equity 00000



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue71,571
Cost of Revenue-67,194
Gross Profit4,3784,378
 
Operating Income (+$)
Gross Profit4,378
Operating Expense-74,607
Operating Income-3,035-70,229
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense74,6070
 
Net Interest Income (+$)
Interest Income13
Interest Expense-948
Other Finance Cost-0
Net Interest Income-935
 
Pretax Income (+$)
Operating Income-3,035
Net Interest Income-935
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,179-3,035
EBIT - interestExpense = -948
-3,232
-2,283
Interest Expense948
Earnings Before Interest and Taxes (EBIT)0-3,231
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-4,179
Tax Provision--245
Net Income From Continuing Ops-3,934-3,934
Net Income-3,232
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0935
 

Technical Analysis of Farmacosmo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Farmacosmo. The general trend of Farmacosmo is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Farmacosmo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Farmacosmo SpA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.6 < 0.612 < 0.648.

The bearish price targets are: .

Tweet this
Farmacosmo SpA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Farmacosmo SpA. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Farmacosmo SpA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Farmacosmo SpA. The current macd is -0.06189057.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Farmacosmo price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Farmacosmo. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Farmacosmo price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Farmacosmo SpA Daily Moving Average Convergence/Divergence (MACD) ChartFarmacosmo SpA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Farmacosmo SpA. The current adx is 48.58.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Farmacosmo shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Farmacosmo SpA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Farmacosmo SpA. The current sar is 0.536.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Farmacosmo SpA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Farmacosmo SpA. The current rsi is 19.49. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Farmacosmo SpA Daily Relative Strength Index (RSI) ChartFarmacosmo SpA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Farmacosmo SpA. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Farmacosmo price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Farmacosmo SpA Daily Stochastic Oscillator ChartFarmacosmo SpA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Farmacosmo SpA. The current cci is -163.6522291.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Farmacosmo SpA Daily Commodity Channel Index (CCI) ChartFarmacosmo SpA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Farmacosmo SpA. The current cmo is -69.71093008.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Farmacosmo SpA Daily Chande Momentum Oscillator (CMO) ChartFarmacosmo SpA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Farmacosmo SpA. The current willr is -96.3898917.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Farmacosmo SpA Daily Williams %R ChartFarmacosmo SpA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Farmacosmo SpA.

Farmacosmo SpA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Farmacosmo SpA. The current atr is 0.04076054.

Farmacosmo SpA Daily Average True Range (ATR) ChartFarmacosmo SpA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Farmacosmo SpA. The current obv is -2,308,256.

Farmacosmo SpA Daily On-Balance Volume (OBV) ChartFarmacosmo SpA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Farmacosmo SpA. The current mfi is 22.67.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Farmacosmo SpA Daily Money Flow Index (MFI) ChartFarmacosmo SpA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Farmacosmo SpA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Farmacosmo SpA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Farmacosmo SpA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.491
Ma 20Greater thanMa 500.555
Ma 50Greater thanMa 1000.625
Ma 100Greater thanMa 2000.671
OpenGreater thanClose0.400
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Farmacosmo with someone you think should read this too:
  • Are you bullish or bearish on Farmacosmo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Farmacosmo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Farmacosmo SpA

I send you an email if I find something interesting about Farmacosmo SpA.


Comments

How you think about this?

Leave a comment

Stay informed about Farmacosmo SpA.

Receive notifications about Farmacosmo SpA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.